Skip to main content

Advertisement

Log in

The Relationship between Patients’ Serum Glucose Levels and Metabolically Active Brown Adipose Tissue Detected by PET/CT

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

To compare blood glucose levels in patients with or without “detectable” brown adipose tissue (BAT) using 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT).

Procedures

Nine hundred eight patients had PET/CT scans and were previously identified as having, or not having, FDG uptake in BAT. The original database was retrospectively reviewed for blood glucose level and body mass index (BMI) at the time of imaging. Blood glucose levels were compared between patients with or without FDG uptake in BAT, adjusting for age, sex, and BMI.

Results

Fifty-six patients (6.2%) had FDG uptake in BAT. In the univariate analysis, patients without FDG uptake in BAT had a higher risk of glucose ≥100 mg/dL (odds ratio 3.4, 95% CI = 1.6-7.3; P = 0.0007). After adjustment for age, sex, BMI, and significant interaction of sex and BMI, patients without BAT tended to have a higher risk of glucose ≥100 mg/dL, although not statistically significant (odds ratio = 1.6, 95% CI = 0.7-3.6; P = 0.268).

Conclusions

Although causal relationships are not specified, the data suggest that BAT uptake, glucose levels, BMI, sex, and age are inter-related and the possibility that presence of “detectable” BAT is protective against diabetes and obesity. FDG PET/CT may be a vital tool for further investigations of diabetes and obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rosen ED, Spiegelman BM (2000) Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145–171

    Article  PubMed  CAS  Google Scholar 

  2. Cohade C, Osman M, Pannu HK, Wahl RL (2003) Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med 44:170–176

    PubMed  CAS  Google Scholar 

  3. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398

    Article  PubMed  Google Scholar 

  4. Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444–E452

    Article  PubMed  CAS  Google Scholar 

  5. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM et al (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360:1500–1508

    Article  PubMed  Google Scholar 

  6. Cypess AM, Lehman S, Williams G et al (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509–1517

    Article  PubMed  CAS  Google Scholar 

  7. Virtanen KA, Lidell ME, Orava J et al (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360:1518–1525

    Article  PubMed  CAS  Google Scholar 

  8. Bar-Shalom R, Gaitini D, Keidar Z, Israel O (2004) Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31:1105–1113

    Article  PubMed  CAS  Google Scholar 

  9. Baba S, Engles JM, Huso DL, Ishimori T, Wahl RL (2007) Comparison of uptake of multiple clinical radiotracers into brown adipose tissue under cold-stimulated and nonstimulated conditions. J Nucl Med 48:1715–1723

    Article  PubMed  Google Scholar 

  10. Baba S, Tatsumi M, Ishimori T, Lilien DL, Engles JM, Wahl RL (2007) Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue. J Nucl Med 48:981–986

    Article  PubMed  CAS  Google Scholar 

  11. Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL (2004) Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45:1189–1193

    PubMed  CAS  Google Scholar 

  12. Cohade C, Mourtzikos KA, Wahl RL (2003) "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 44:1267–1270

    PubMed  Google Scholar 

  13. Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS (1995) Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266–1273

    Article  PubMed  CAS  Google Scholar 

  14. Hamann A, Flier JS, Lowell BB (1996) Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21–29

    Article  PubMed  CAS  Google Scholar 

  15. Lowell BB, Susulic V, Hamann A et al (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742

    Article  PubMed  CAS  Google Scholar 

  16. Ortmann S, Prinzler J, Klaus S (2003) Self-selected macronutrient diet affects energy and glucose metabolism in brown fat-ablated mice. Obes Res 11:1536–1544

    Article  PubMed  CAS  Google Scholar 

  17. Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diab Care 26:3160–3167

    Article  Google Scholar 

  18. National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res 6:51 S-209 S.

    Google Scholar 

  19. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM (2003) Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false positives for PET. J Nucl Med 44:1789–1796

    PubMed  Google Scholar 

  20. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW (1994) Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6 J ob/ob) mice. Mol Endocrinol 8:518–527

    Article  PubMed  CAS  Google Scholar 

  21. Marette A, Mauriege P, Despres JP, Tulp OL, Bukowiecki LJ (1993) Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats. Am J Physiol 265:R577–R583

    PubMed  CAS  Google Scholar 

  22. Ghorbani M, Himms-Hagen J (1997) Appearance of brown adipocytes in white adipose tissue during CL 316, 243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord 21:465–475

    Article  PubMed  CAS  Google Scholar 

  23. Williams G, Kolodny GM (2008) Methods for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR Am J Roentgenol 190:1406–1409

    Article  PubMed  Google Scholar 

  24. Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard L. Wahl.

Additional information

Significance:

This paper demonstrates that FDG PET/CT may be a vital tool for further investigations of diabetes and obesity and the possibility that the presence of “detectable” BAT is protective against diabetes and obesity.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacene, H.A., Cohade, C.C., Zhang, Z. et al. The Relationship between Patients’ Serum Glucose Levels and Metabolically Active Brown Adipose Tissue Detected by PET/CT. Mol Imaging Biol 13, 1278–1283 (2011). https://doi.org/10.1007/s11307-010-0379-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-010-0379-9

Key words

Navigation